BiocardiaInc Current Deferred Revenue vs Capital Stock Analysis

BCDA Stock

USD 0.38 0.01 2.70%

BiocardiaInc financial indicator trend analysis is way more than just evaluating BiocardiaInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BiocardiaInc is a good investment. Please check the relationship between BiocardiaInc Current Deferred Revenue and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.

Current Deferred Revenue vs Capital Stock

Current Deferred Revenue vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BiocardiaInc Current Deferred Revenue account and Capital Stock. At this time, the significance of the direction appears to have pay attention.

The correlation between BiocardiaInc's Current Deferred Revenue and Capital Stock is -0.71. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Capital Stock in the same time period over historical financial statements of BiocardiaInc, assuming nothing else is changed. The correlation between historical values of BiocardiaInc's Current Deferred Revenue and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of BiocardiaInc are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Current Deferred Revenue i.e., BiocardiaInc's Current Deferred Revenue and Capital Stock go up and down completely randomly.

Correlation Coefficient

-0.71

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Most indicators from BiocardiaInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BiocardiaInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.At present, BiocardiaInc's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 12.57, whereas Selling General Administrative is forecasted to decline to about 3.3 M.

	2021	2022	2023	2024 (projected)
Interest Expense	9K	6K	6.9K	6.6K
Depreciation And Amortization	67K	82K	411K	242.0K

Interest Expense Depreciation And Amortization

BiocardiaInc fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Short Term Investments	Current Deferred Revenue	Good Will	Inventory
Total Assets		-0.36	-0.14	0.96	-0.15	-0.97	0.16	-0.24	0.99	-0.26	-0.61	0.99	0.3	0.54	-0.3	0.23	0.33	-0.06	-0.2	-0.37	0.99	0.54	0.65	0.11	0.51	-0.19
Other Current Liab	-0.36		0.94	-0.61	0.78	0.55	-0.89	0.7	-0.48	0.84	0.65	-0.48	-0.16	-0.75	0.82	0.72	0.54	0.86	0.96	0.79	-0.45	-0.75	-0.39	0.71	-0.52	-0.76
Total Current Liabilities	-0.14	0.94		-0.42	0.75	0.34	-0.94	0.8	-0.27	0.78	0.48	-0.27	-0.08	-0.71	0.76	0.78	0.61	0.93	0.98	0.7	-0.23	-0.71	-0.2	0.85	-0.38	-0.89
Total Stockholder Equity	0.96	-0.61	-0.42		-0.39	-0.99	0.42	-0.44	0.99	-0.49	-0.71	0.99	0.32	0.7	-0.51	-0.02	0.15	-0.33	-0.47	-0.57	0.98	0.69	0.64	-0.14	0.56	0.07
Property Plant And Equipment Net	-0.15	0.78	0.75	-0.39		0.36	-0.79	0.4	-0.27	0.96	0.57	-0.27	-0.19	-0.58	0.79	0.7	0.28	0.76	0.85	0.89	-0.26	-0.57	-0.02	0.71	-0.18	-0.59
Net Debt	-0.97	0.55	0.34	-0.99	0.36		-0.35	0.35	-1.0	0.46	0.72	-1.0	-0.32	-0.66	0.48	-0.03	-0.2	0.25	0.4	0.55	-0.99	-0.65	-0.65	0.08	-0.55	0.01
Retained Earnings	0.16	-0.89	-0.94	0.42	-0.79	-0.35		-0.78	0.27	-0.83	-0.58	0.27	0.22	0.6	-0.89	-0.68	-0.45	-0.99	-0.95	-0.8	0.25	0.59	0.2	-0.77	0.51	0.89
Accounts Payable	-0.24	0.7	0.8	-0.44	0.4	0.35	-0.78		-0.32	0.45	0.29	-0.32	-0.31	-0.56	0.53	0.39	0.37	0.76	0.75	0.43	-0.29	-0.56	-0.19	0.6	-0.39	-0.71
Cash	0.99	-0.48	-0.27	0.99	-0.27	-1.0	0.27	-0.32		-0.38	-0.67	1.0	0.31	0.62	-0.4	0.11	0.24	-0.18	-0.33	-0.47	1.0	0.62	0.65	-0.01	0.53	-0.08
Non Current Assets Total	-0.26	0.84	0.78	-0.49	0.96	0.46	-0.83	0.45	-0.38		0.73	-0.38	-0.24	-0.61	0.88	0.67	0.26	0.81	0.88	0.97	-0.37	-0.61	-0.25	0.7	-0.41	-0.6
Non Currrent Assets Other	-0.61	0.65	0.48	-0.71	0.57	0.72	-0.58	0.29	-0.67	0.73		-0.67	-0.27	-0.53	0.8	0.25	-0.06	0.54	0.55	0.8	-0.67	-0.52	-0.78	0.32	-0.74	-0.27
Cash And Short Term Investments	0.99	-0.48	-0.27	0.99	-0.27	-1.0	0.27	-0.32	1.0	-0.38	-0.67		0.31	0.62	-0.4	0.11	0.24	-0.18	-0.33	-0.47	1.0	0.62	0.65	-0.01	0.53	-0.08
Net Receivables	0.3	-0.16	-0.08	0.32	-0.19	-0.32	0.22	-0.31	0.31	-0.24	-0.27	0.31		-0.11	-0.25	0.38	0.16	-0.2	-0.18	-0.41	0.32	-0.12	0.12	0.14	0.33	-0.12
Common Stock Total Equity	0.54	-0.75	-0.71	0.7	-0.58	-0.66	0.6	-0.56	0.62	-0.61	-0.53	0.62	-0.11		-0.57	-0.56	-0.28	-0.53	-0.7	-0.54	0.6	1.0	0.35	-0.71	0.28	0.46
Common Stock Shares Outstanding	-0.3	0.82	0.76	-0.51	0.79	0.48	-0.89	0.53	-0.4	0.88	0.8	-0.4	-0.25	-0.57		0.57	0.26	0.88	0.81	0.91	-0.39	-0.56	-0.4	0.61	-0.69	-0.69
Non Current Liabilities Total	0.23	0.72	0.78	-0.02	0.7	-0.03	-0.68	0.39	0.11	0.67	0.25	0.11	0.38	-0.56	0.57		0.68	0.69	0.76	0.48	0.14	-0.56	0.05	0.81	-0.06	-0.82
Other Current Assets	0.33	0.54	0.61	0.15	0.28	-0.2	-0.45	0.37	0.24	0.26	-0.06	0.24	0.16	-0.28	0.26	0.68		0.48	0.52	0.12	0.29	-0.28	0.13	0.56	-0.01	-0.67
Other Stockholder Equity	-0.06	0.86	0.93	-0.33	0.76	0.25	-0.99	0.76	-0.18	0.81	0.54	-0.18	-0.2	-0.53	0.88	0.69	0.48		0.93	0.77	-0.16	-0.53	-0.18	0.77	-0.51	-0.91
Total Liab	-0.2	0.96	0.98	-0.47	0.85	0.4	-0.95	0.75	-0.33	0.88	0.55	-0.33	-0.18	-0.7	0.81	0.76	0.52	0.93		0.81	-0.3	-0.7	-0.21	0.82	-0.4	-0.83
Property Plant And Equipment Gross	-0.37	0.79	0.7	-0.57	0.89	0.55	-0.8	0.43	-0.47	0.97	0.8	-0.47	-0.41	-0.54	0.91	0.48	0.12	0.77	0.81		-0.47	-0.53	-0.35	0.57	-0.55	-0.49
Total Current Assets	0.99	-0.45	-0.23	0.98	-0.26	-0.99	0.25	-0.29	1.0	-0.37	-0.67	1.0	0.32	0.6	-0.39	0.14	0.29	-0.16	-0.3	-0.47		0.59	0.65	0.02	0.53	-0.11
Common Stock	0.54	-0.75	-0.71	0.69	-0.57	-0.65	0.59	-0.56	0.62	-0.61	-0.52	0.62	-0.12	1.0	-0.56	-0.56	-0.28	-0.53	-0.7	-0.53	0.59		0.34	-0.71	0.27	0.46
Short Term Investments	0.65	-0.39	-0.2	0.64	-0.02	-0.65	0.2	-0.19	0.65	-0.25	-0.78	0.65	0.12	0.35	-0.4	0.05	0.13	-0.18	-0.21	-0.35	0.65	0.34		0.02	0.8	0.02
Current Deferred Revenue	0.11	0.71	0.85	-0.14	0.71	0.08	-0.77	0.6	-0.01	0.7	0.32	-0.01	0.14	-0.71	0.61	0.81	0.56	0.77	0.82	0.57	0.02	-0.71	0.02		-0.08	-0.79
Good Will	0.51	-0.52	-0.38	0.56	-0.18	-0.55	0.51	-0.39	0.53	-0.41	-0.74	0.53	0.33	0.28	-0.69	-0.06	-0.01	-0.51	-0.4	-0.55	0.53	0.27	0.8	-0.08		0.32
Inventory	-0.19	-0.76	-0.89	0.07	-0.59	0.01	0.89	-0.71	-0.08	-0.6	-0.27	-0.08	-0.12	0.46	-0.69	-0.82	-0.67	-0.91	-0.83	-0.49	-0.11	0.46	0.02	-0.79	0.32

Click cells to compare fundamentals

BiocardiaInc Account Relationship Matchups

BiocardiaInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.7M	23.4M	15.7M	9.8M	3.0M	2.8M
Other Current Liab	1.8M	1.5M	1.4M	1.6M	1.8M	1.9M
Total Current Liabilities	4.0M	4.2M	3.7M	3.6M	3.6M	3.8M
Total Stockholder Equity	2.4M	19.2M	10.4M	4.9M	(1.6M)	(1.5M)
Property Plant And Equipment Net	1.2M	712K	2.1M	1.9M	1.4M	744.1K
Net Debt	(4.4M)	(20.8M)	(11.0M)	(5.7M)	212K	222.6K
Retained Earnings	(101.1M)	(116.1M)	(128.7M)	(140.6M)	(152.2M)	(144.6M)
Accounts Payable	914K	746K	507K	683K	890K	934.5K
Cash	5.6M	21.4M	12.9M	7.4M	1.1M	1.0M
Non Current Assets Total	1.3M	766K	2.2M	1.9M	1.5M	1.6M
Cash And Short Term Investments	5.6M	21.4M	12.9M	7.4M	1.1M	1.0M
Net Receivables	274K	147K	850K	201K	63K	59.9K
Common Stock Total Equity	38K	43K	7K	16K	18.4K	17.5K
Common Stock Shares Outstanding	5.6M	10.1M	16.9M	17.7M	21.2M	22.2M
Liabilities And Stockholders Equity	7.7M	23.4M	15.7M	9.8M	3.0M	2.8M
Non Current Liabilities Total	1.3M	2.7M	1.6M	1.3M	982.0K	630.9K
Other Current Assets	642K	1.3M	462K	501K	295K	452.9K
Other Stockholder Equity	103.4M	135.2M	139.1M	145.5M	150.5M	158.1M
Total Liab	5.3M	4.2M	5.3M	4.9M	4.6M	4.8M
Total Current Assets	6.4M	22.7M	13.5M	7.9M	1.5M	1.4M
Common Stock	7K	16K	17K	20K	24K	22.8K
Current Deferred Revenue	732K	1.4M	1.5M	965K	561K	732.7K
Inventory	4K	(850K)	1.0	(201K)	(180.9K)	(171.9K)
Net Tangible Assets	2.4M	19.2M	10.4M	4.9M	5.6M	5.5M
Retained Earnings Total Equity	(72.5M)	(86.4M)	(101.1M)	(116.1M)	(104.5M)	(99.2M)
Capital Surpluse	83.5M	90.1M	103.4M	135.2M	155.5M	163.3M
Property Plant Equipment	1.2M	712K	2.1M	1.8M	2.0M	2.1M
Net Invested Capital	2.4M	19.2M	10.4M	4.9M	(1.6M)	(1.5M)
Net Working Capital	2.4M	18.4M	9.8M	4.3M	(2.1M)	(2.0M)
Capital Stock	7K	16K	17K	20K	24K	16.9K

Pair Trading with BiocardiaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with BiocardiaInc Stock

0.65

DVAX

Dynavax Technologies Financial Report 7th of May 2024

Pair Corr

Moving against BiocardiaInc Stock

0.57	HCM	HUTCHMED DRC	Pair Corr
0.56	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.51	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr
0.44	FLGC	Flora Growth Corp Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.

The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BiocardiaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BiocardiaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardiainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardiainc Stock:

How To Invest In BiocardiaInc

Details

Is BiocardiaInc Stock a good investment?

Details

What is BiocardiaInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.

Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for BiocardiaInc Stock analysis

When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.

	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Global Correlations Find global opportunities by holding instruments from different markets
	Transaction History View history of all your transactions and understand their impact on performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Content Syndication Quickly integrate customizable finance content to your own investment portal

Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.55)

Revenue Per Share

0.023

Quarterly Revenue Growth

(0.88)

Return On Assets

(1.14)

Return On Equity

(7.04)

The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BiocardiaInc Current Deferred Revenue vs Capital Stock Analysis

Current Deferred Revenue vs Capital Stock

Current Deferred Revenue vs Capital Stock Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Capital Stock

BiocardiaInc fundamental ratios Correlations

BiocardiaInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BiocardiaInc fundamental ratios Accounts

Pair Trading with BiocardiaInc

Moving together with BiocardiaInc Stock

Moving against BiocardiaInc Stock

Complementary Tools for BiocardiaInc Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Retained Earnings
Total Current Assets	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.97	Total Assets